BioCryst Pharmaceuticals | BCRX - Pe Prix À Revenus





Pe Changement Date
Alnylam Pharmaceuticals 75.64 4.4 2026-06
BioCryst Pharmaceuticals 6.84 0.78 2026-06
Chugai Pharma 24.32 4.56 2026-06
Daiichi Sankyo 20.14 0.6 2026-06
Gilead Sciences 13.51 4.2 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Glaxosmithkline 15.09 3.43 2026-03
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 22.1 5.99 2026-06
Novavax 2.01 1.07 2025-12
PTC Therapeutics 8.76 1.22 2026-03
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sarepta Therapeutics 27.27 0 2026-03
Vertex Pharmaceuticals 28.05 2.22 2026-06